Lowered Organic Growth OutlookMIR did also lower its organic growth outlook, and investors would like to see MIR demonstrate more consistent near-term outcomes to support a relatively high valuation multiple.
Near-term Share Issuance ImpactIn the near-term, a combination of lowered organic growth outlook and some expected incremental share issuance associated with the Paragon acquisition is contributing to underperformance in MIR's shares.
Softer Q4 ExpectationsManagement expects a softer Q4, especially in defense and dosimetry, due to order timing and tough comps in U.S. RTQA and delayed European defense orders.